Warning letter
Apotheca Supply, Inc: warning letter of Apr 7, 2016
FDA warning letter 460921 · New Orleans District Office
Key facts
| Reference number | 460921 |
|---|---|
| Company | Apotheca Supply, Inc |
| Subject | CGMP/Active Pharmaceutical Ingredient (API)/Adulterated |
| Issue date | Apr 7, 2016 |
| Posted date | May 3, 2016 |
| Issuing office | New Orleans District Office |
| Product type | Drugs |
| Inspection city | Decatur |
| Inspection ZIP | 35603 |
| Inspection start date | Feb 10, 2015 |
| Letter on fda.gov | web.archive.org |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: